Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis.
作者信息
Haddox C L, Mangaonkar A A, Chen D, Shi M, He R, Oliveira J L, Litzow M R, Al-Kali A, Hogan W J, Elliott M A
机构信息
Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Division of Hematology/Oncology, Mayo Clinic, Rochester, MN, USA.
出版信息
Blood Cancer J. 2017 Sep 15;7(9):e607. doi: 10.1038/bcj.2017.89.
Abstract
摘要
Zotero 插件